陽子線治療市場：製品タイプ、システムタイプ、治療法、用途、エンドユーザー別-2025-2030年の世界予測

陽子線治療市場は、2023年に5億1,183万米ドルと評価され、2024年には5億6,224万米ドルに達すると予測され、CAGR 9.92%で成長し、2030年には9億9,242万米ドルに達すると予測されています。

放射線治療の革命的な形態である陽子線治療は、主に陽子ビームで腫瘍を標的にすることでがんを治療するために使用され、陽子のユニークな特性を活用して、周囲の健康な組織を温存しながらがん細胞を正確に破壊します。陽子線治療の適用範囲は前立腺がん、脳腫瘍、小児がんなど様々ながんに及び、従来の治療法が重要な臓器に高いリスクをもたらす場合にこの治療法が必要であることを強調しています。このような需要の高まりは、がん罹患率の増加や先進的な治療オプションに対する意識の高まり、技術的進歩や有利な規制の枠組みが後押ししています。重要な成長促進要因としては、ビーム照射方法の技術革新の進行や、世界の陽子線治療センターの設置拡大が挙げられます。主なビジネスチャンスとしては、治療へのアクセスや普及を高めるための併用療法や費用対効果に関する調査の拡大が挙げられます。しかし、陽子線治療センターの設置や運営にかかるコストが高いこと、低所得地域では利用可能な施設やアクセスが限られていること、ヘルスケア専門家に対する高度な専門トレーニングが必要であることなど、市場は注目すべき課題に直面しています。また、競合情勢の進化、初期設備投資の高さ、保険償還政策の複雑さもハードルとなっています。これらの課題を克服するために、利害関係者は、コスト削減と導入効率の向上を約束する小型陽子線治療システムの技術的進歩のための協力関係の育成に注力すべきです。さらに、臨床試験や縦断的研究を重視し、有効性、費用対効果、長期的転帰をさらに検証することで、採用率を高めることができます。陽子線治療と免疫療法や新しいナノ粒子との統合や、治療中の腫瘍の変化に対応する適応型陽子線治療技術の開発など、革新的な研究分野の開拓が必要です。この市場の性質は、急速な技術進化と大きな投資の可能性を特徴とするダイナミックなものであり、戦略的提携や官民パートナーシップは、世界の事業展開と患者へのリーチの拡大を促進することができます。

市場力学：急速に進化する陽子線治療市場の主要市場インサイトを公開

陽子線治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界中で増加するがんや腫瘍の発生率
  • がん治療施設の拡大と効果的ながん治療の必要性に対する意識の高まり
  • 陽子線治療に対する政府および規制当局の好意的支援
• 市場抑制要因
  • 陽子線治療治療のための専門人材の必要性
• 市場機会
  • 陽子線治療の有効性と効果を向上させるための継続的な調査と進歩
  • 陽子線治療と他のがん治療戦略との併用治療の可能性
• 市場の課題
  • 副作用や有効性に関する複雑な問題

ポーターのファイブフォース：陽子線治療市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：陽子線治療市場における外部からの影響の把握

外部マクロ環境要因は、陽子線治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析陽子線治療市場における競合情勢の把握

陽子線治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス陽子線治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、陽子線治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨陽子線治療市場における成功への道筋を描く

陽子線治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でがんや腫瘍の発生率が増加
    • がん治療施設の拡大と効果的ながん治療の必要性に対する意識の高まり
    • 陽子線治療に対する政府と規制当局の好意的なサポート
  • 抑制要因
    • 陽子線治療治療のための専門人材の必要性
  • 機会
    • 陽子線治療の有効性と効果を向上させるための継続的な調査と進歩
    • 陽子線治療と他のがん治療戦略との組み合わせの可能性
  • 課題
    • 副作用と有効性の問題の複雑さ
• 市場セグメンテーション分析
  • 製品：陽子線治療機器の機能と性能を向上させるための多大な努力
  • 用途：副作用の可能性を減らすために小児がんに対する陽子線治療の優先
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 陽子線治療市場：製品別

• 装置
  • アクセル
  • ビームデリバリーシステム
  • ビーム輸送システム
  • ノズルと画像ビューア
  • 患者位置決めシステム
• サービス
• ソフトウェア

第7章 陽子線治療市場システムタイプ別

• マルチルームシステム
• シングルルームシステム

第8章 陽子線治療市場セラピー

• 従来の陽子線治療
• ペンシルビームスキャン

第9章 陽子線治療市場：用途別

• 大腸がん
• 肺がん
• 小児がん
• 前立腺がん

第10章 陽子線治療市場：エンドユーザー別

• 外来手術センター
• 病院
• 専門クリニック

第11章 南北アメリカの陽子線治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の陽子線治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの陽子線治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 全身MRI誘導陽子線治療プロトタイプがドレスデンのOncoRayで公開され、腫瘍追跡と治療精度の向上を目指している
  • 日立、東南アジア初の先進的陽子線治療システムをNCCSに納入、がん治療の精度向上に貢献
  • アポロ病院、チェンナイに南アジアの陽子線治療センターを開設、ベルギー企業との拡張および提携を発表
• 戦略分析と提言

企業一覧

• Accuray Incorporated
• Advanced Oncotherapy PLC
• Elekta AB
• Hitachi Ltd.
• Ion Beam Applications SA
• Koninklijke Philips N.V.
• Medaustron
• Mevion Medical Systems, Inc.
• Mitsubishi Electric Corporation
• Optivus Proton Therapy, Inc.
• Panacea Medical Technologies Pvt Ltd.
• Philips Healthcare
• ProNova Solutions, LLC
• ProTon International
• Protonic Medical Systems Private Limited
• Provision Healthcare, LLC
• PTW Freiburg GmbH
• RaySearch Laboratories AB
• Sumitomo Heavy Industries Ltd.
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. PROTON THERAPY MARKET RESEARCH PROCESS
• FIGURE 2. PROTON THERAPY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PROTON THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PROTON THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PROTON THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PROTON THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PROTON THERAPY MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PROTON THERAPY MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PROTON THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PROTON THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL PROTON THERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL PROTON THERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES PROTON THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES PROTON THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. PROTON THERAPY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. PROTON THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PROTON THERAPY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PROTON THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PROTON THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PROTON THERAPY MARKET DYNAMICS
• TABLE 7. GLOBAL PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PROTON THERAPY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PROTON THERAPY MARKET SIZE, BY ACCELERATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PROTON THERAPY MARKET SIZE, BY BEAM DELIVERY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PROTON THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PROTON THERAPY MARKET SIZE, BY NOZZLE & IMAGE VIEWERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PROTON THERAPY MARKET SIZE, BY PATIENT POSITIONING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PROTON THERAPY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PROTON THERAPY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PROTON THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PROTON THERAPY MARKET SIZE, BY SINGLE ROOM SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PROTON THERAPY MARKET SIZE, BY CONVENTIONAL PROTON THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PROTON THERAPY MARKET SIZE, BY PENCIL BEAM SCANNING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PROTON THERAPY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PROTON THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PROTON THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PROTON THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PROTON THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PROTON THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PROTON THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. CANADA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. CANADA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 53. CANADA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 54. CANADA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 55. CANADA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. CANADA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES PROTON THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. CHINA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. CHINA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 85. CHINA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 86. CHINA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 87. CHINA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. CHINA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. INDIA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. INDIA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 91. INDIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 92. INDIA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 93. INDIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. INDIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. ITALY PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. ITALY PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 194. ITALY PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 195. ITALY PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 196. ITALY PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. ITALY PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 216. POLAND PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. POLAND PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 218. POLAND PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 219. POLAND PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 220. POLAND PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. POLAND PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. QATAR PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. QATAR PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 224. QATAR PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 225. QATAR PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 226. QATAR PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. QATAR PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM PROTON THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM PROTON THERAPY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM PROTON THERAPY MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM PROTON THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM PROTON THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 282. PROTON THERAPY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 283. PROTON THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

The Proton Therapy Market was valued at USD 511.83 million in 2023, expected to reach USD 562.24 million in 2024, and is projected to grow at a CAGR of 9.92%, to USD 992.42 million by 2030.

Proton therapy, a revolutionary form of radiation therapy, is used primarily to treat cancer by targeting tumors with proton beams, leveraging the unique properties of protons to destroy cancer cells with precision while sparing surrounding healthy tissues. The application scope of proton therapy extends across various cancers, including prostate, brain, and pediatric cancers, emphasizing the treatment's necessity when conventional therapies pose high risks to critical organs. This growing demand is fueled by increasing cancer prevalence and rising awareness of advanced therapeutic options, dovetailing with technological advancements and favorable regulatory frameworks. Significant growth drivers include ongoing innovation in beam delivery methods and expanding installations of proton therapy centers globally. Key opportunities involve expanding research on combination therapies and cost-effectiveness to enhance treatment accessibility and uptake. However, the market faces noteworthy challenges, including high costs of installation and operation of proton therapy centers, limited availability and accessibility in low-income regions, and the need for highly specialized training for healthcare professionals. The evolving competitive landscape, high initial capital investment, and complexities in insurance reimbursement policies also pose hurdles. To surmount these challenges, stakeholders should focus on fostering collaborations for technological advancements in compact proton therapy systems, which promise reduced costs and increased deployment efficiency. Additionally, increasing the emphasis on clinical trials and longitudinal studies to further validate the efficacy, cost-efficiency, and long-term outcomes can boost adoption rates. Innovative research areas ripe for exploration include the development of hybrid treatment modalities, such as integrating proton therapy with immunotherapy or emerging nanoparticles and advancing adaptive proton therapy techniques that adjust to tumor changes during treatment. The market's nature remains dynamic, characterized by rapid technological evolution and significant investment potential, where strategic alliances and public-private partnerships can catalyze an expanded global footprint and patient reach.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Proton Therapy Market

The Proton Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of cancers and tumors across the world
  • Expansion of cancer care facilities and growing awareness about the need for effective cancer treatments
  • Favorable government and regulatory support for proton therapy
• Market Restraints
  • Need for specialized personnel for proton therapy treatment
• Market Opportunities
  • Ongoing research and advancements to improve the efficacy and effectiveness of proton therapy
  • Possibility of combination of proton therapy with other cancer treatment strategies
• Market Challenges
  • Complexities of side effects and efficacy issues

Porter's Five Forces: A Strategic Tool for Navigating the Proton Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Proton Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Proton Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Proton Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Proton Therapy Market

A detailed market share analysis in the Proton Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Proton Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Proton Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Proton Therapy Market

A strategic analysis of the Proton Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Proton Therapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Advanced Oncotherapy PLC, Elekta AB, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Medaustron, Mevion Medical Systems, Inc., Mitsubishi Electric Corporation, Optivus Proton Therapy, Inc., Panacea Medical Technologies Pvt Ltd., Philips Healthcare, ProNova Solutions, LLC, ProTon International, Protonic Medical Systems Private Limited, Provision Healthcare, LLC, PTW Freiburg GmbH, RaySearch Laboratories AB, Sumitomo Heavy Industries Ltd., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Proton Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Equipment, Services, and Software. The Equipment is further studied across Accelerator, Beam Delivery System, Beam Transport System, Nozzle & Image Viewers, and Patient Positioning System.
• Based on System Type, market is studied across Multi-Room System and Single Room System.
• Based on Therapy, market is studied across Conventional Proton Therapy and Pencil Beam Scanning.
• Based on Application, market is studied across Colorectal Cancer, Lung Cancer, Pediatric Cancer, and Prostate Cancer.
• Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of cancers and tumors across the world
    • 5.1.1.2. Expansion of cancer care facilities and growing awareness about the need for effective cancer treatments
    • 5.1.1.3. Favorable government and regulatory support for proton therapy
  • 5.1.2. Restraints
    • 5.1.2.1. Need for specialized personnel for proton therapy treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and advancements to improve the efficacy and effectiveness of proton therapy
    • 5.1.3.2. Possibility of combination of proton therapy with other cancer treatment strategies
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities of side effects and efficacy issues
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Significant efforts directed to improve the functionality and performance of proton therapy equipment
  • 5.2.2. Application: Preference for proton therapy for pediatric cancer to reduce the possibility of side effects
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Proton Therapy Market, by Product

• 6.1. Introduction
• 6.2. Equipment
  • 6.2.1. Accelerator
  • 6.2.2. Beam Delivery System
  • 6.2.3. Beam Transport System
  • 6.2.4. Nozzle & Image Viewers
  • 6.2.5. Patient Positioning System
• 6.3. Services
• 6.4. Software

7. Proton Therapy Market, by System Type

• 7.1. Introduction
• 7.2. Multi-Room System
• 7.3. Single Room System

8. Proton Therapy Market, by Therapy

• 8.1. Introduction
• 8.2. Conventional Proton Therapy
• 8.3. Pencil Beam Scanning

9. Proton Therapy Market, by Application

• 9.1. Introduction
• 9.2. Colorectal Cancer
• 9.3. Lung Cancer
• 9.4. Pediatric Cancer
• 9.5. Prostate Cancer

10. Proton Therapy Market, by End User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Hospitals
• 10.4. Specialty Clinics

11. Americas Proton Therapy Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Proton Therapy Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Proton Therapy Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Whole-Body MRI-Guided Proton Therapy Prototype Unveiled at OncoRay in Dresden, Aiming to Improve Tumor Tracking and Treatment Precision
  • 14.3.2. Hitachi Delivers Southeast Asia's First Advanced Proton Therapy System to NCCS, Enhancing Precision in Cancer Treatment
  • 14.3.3. Apollo Hospitals Launches South Asia's Proton Therapy Center in Chennai, Announces Expansion and Partnership with Belgian Company
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Accuray Incorporated
• 2. Advanced Oncotherapy PLC
• 3. Elekta AB
• 4. Hitachi Ltd.
• 5. Ion Beam Applications SA
• 6. Koninklijke Philips N.V.
• 7. Medaustron
• 8. Mevion Medical Systems, Inc.
• 9. Mitsubishi Electric Corporation
• 10. Optivus Proton Therapy, Inc.
• 11. Panacea Medical Technologies Pvt Ltd.
• 12. Philips Healthcare
• 13. ProNova Solutions, LLC
• 14. ProTon International
• 15. Protonic Medical Systems Private Limited
• 16. Provision Healthcare, LLC
• 17. PTW Freiburg GmbH
• 18. RaySearch Laboratories AB
• 19. Sumitomo Heavy Industries Ltd.
• 20. Thermo Fisher Scientific, Inc.